AMNIOWELL Trademark

Trademark Overview


On Thursday, February 18, 2021, a trademark application was filed for AMNIOWELL with the United States Patent and Trademark Office. The USPTO has given the AMNIOWELL trademark a serial number of 90534371. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, April 18, 2022. This trademark is owned by AMNIOWELL CORP.. The AMNIOWELL trademark is filed in the Advertising, Business and Retail Services category with the following description:

On-line ordering services featuring on-line ordering services featuring natural health care products, namely, placental and acellular protein peptide allografts intended for homologous use in the fields of beauty, sexual wellness, regenerative medicine, pain management, pain alleviation, immunity enhancement, nutrition enhancement, skin health rejuvenation, inflammation management and mitigation, wound care, burn treatment, bodily injury treatment, hair treatment and scalp treatment; providing an internet website featuring news and information about natural health care products, namely, placental and acellular protein peptide allografts intended for homologous use in the fields of beauty, sexual wellness, regenerative medicine, pain management, pain alleviation, immunity enhancement, nutrition enhancement, skin health rejuvenation, inflammation management and mitigation, wound care, burn treatment, bodily injury treatment, hair treatment and scalp treatment
amniowell

General Information


Serial Number90534371
Word MarkAMNIOWELL
Filing DateThursday, February 18, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, April 18, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesOn-line ordering services featuring on-line ordering services featuring natural health care products, namely, placental and acellular protein peptide allografts intended for homologous use in the fields of beauty, sexual wellness, regenerative medicine, pain management, pain alleviation, immunity enhancement, nutrition enhancement, skin health rejuvenation, inflammation management and mitigation, wound care, burn treatment, bodily injury treatment, hair treatment and scalp treatment; providing an internet website featuring news and information about natural health care products, namely, placental and acellular protein peptide allografts intended for homologous use in the fields of beauty, sexual wellness, regenerative medicine, pain management, pain alleviation, immunity enhancement, nutrition enhancement, skin health rejuvenation, inflammation management and mitigation, wound care, burn treatment, bodily injury treatment, hair treatment and scalp treatment

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, May 20, 2021
Primary Code035
First Use Anywhere DateTuesday, March 31, 2020
First Use In Commerce DateTuesday, March 31, 2020

Trademark Owner History


Party NameAMNIOWELL CORP.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDelray Beach, FL 33455

Trademark Events


Event DateEvent Description
Tuesday, April 19, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, April 18, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, April 18, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, October 4, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 4, 2021NON-FINAL ACTION E-MAILED
Monday, October 4, 2021NON-FINAL ACTION WRITTEN
Monday, September 13, 2021ASSIGNED TO EXAMINER
Thursday, May 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 19, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, March 19, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, February 22, 2021NEW APPLICATION ENTERED IN TRAM